UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 283

Sortiert nach

The 12th international conference on differentiation therapy: targeting the aberrant growth, differentiation and cell death programs of cancer cells

Cell death and differentiation, 2011-07, Vol.18 (7), p.1231-1233

2011

Volltextzugriff (PDF)

28-kDa Mammalian Heat Shock Protein, a Novel Substrate of a Growth Regulatory Protease Involved in Differentiation of Human Leukemia Cells (∗)

The Journal of biological chemistry, 1995-01, Vol.270 (3), p.1003-1006

1995

Volltextzugriff (PDF)

9-cis Retinoic Acid Induces Complete Remission But Does Not Reverse Clinically Acquired Retinoid Resistance in Acute Promyelocytic Leukemia

Blood, 1995-06, Vol.85 (11), p.3021-3027

1995

Volltextzugriff (PDF)

9-cis Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein

Cancer research (Chicago, Ill.), 1994-12, Vol.54 (24), p.6549-6556

1994

Volltextzugriff (PDF)

Acute respiratory distress syndrome, acute kidney injury, and mortality after trauma are associated with increased circulation of syndecan-1, soluble thrombomodulin, and receptor for advanced glycation end products

The journal of trauma and acute care surgery, 2024-02, Vol.96 (2), p.319

2024

Volltextzugriff (PDF)

Adverse events associated with immune checkpoint inhibitor treatment for cancer

Canadian Medical Association journal (CMAJ), 2019-01, Vol.191 (2), p.E40

2019

Volltextzugriff (PDF)

Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy

The New England journal of medicine, 2019-06, Vol.380 (24), p.2375-2376

2019

Volltextzugriff (PDF)

All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-α and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas

Differentiation (London), 1994, Vol.55 (2), p.145-152

1994

Volltextzugriff (PDF)

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

Annals of internal medicine, 1994-02, Vol.120 (4), p.278

1994

Volltextzugriff (PDF)

Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia

Blood, 2000-11, Vol.96 (9), p.3200-3208

2000

Volltextzugriff (PDF)

Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling

Toxicology letters, 2006-01, Vol.160 (2), p.158-170

2006

Volltextzugriff (PDF)

Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal Antibodies

JNCI : Journal of the National Cancer Institute, 1993-08, Vol.85 (16), p.1327-1333

1993

Volltextzugriff (PDF)

Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study

Critical reviews in oncology/hematology, 2011-05, Vol.78 (2), p.138-149

2011

Volltextzugriff (PDF)

Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells

JNCI : Journal of the National Cancer Institute, 1998-01, Vol.90 (2), p.124-133

1998

Volltextzugriff (PDF)

Arsenic trioxide decreases AKT protein in a caspase-dependent manner

Molecular cancer therapeutics, 2008-06, Vol.7 (6), p.1680-1687

2008

Volltextzugriff (PDF)

Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRα phosphorylation

The Journal of clinical investigation, 2005-10, Vol.115 (10), p.2924-2933

2005

Volltextzugriff (PDF)

Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation

The Journal of clinical investigation, 2005-10, Vol.115 (10), p.2924

2005

Volltextzugriff (PDF)

Arsenic trioxide: Mechanisms of action

Seminars in hematology, 2002-04, Vol.39 (2), p.3-7

2002

Volltextzugriff (PDF)

Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer

PloS one, 2013-12, Vol.8 (12), p.e85995-e85995

2013

Volltextzugriff (PDF)

Aspartate 351 of Estrogen Receptor Î± Is Not Crucial for the Antagonist Activity of Antiestrogens

The Journal of biological chemistry, 2000-07, Vol.275 (27), p.20867

2000

Volltextzugriff (PDF)

Aspartate 351 of Estrogen Receptor α Is Not Crucial for the Antagonist Activity of Antiestrogens

The Journal of biological chemistry, 2000-07, Vol.275 (27), p.20867-20872

2000

Volltextzugriff (PDF)

Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study

Cancers, 2023-07, Vol.15 (15), p.3753

2023

Volltextzugriff (PDF)

Astroglial cytoprotection by erythropoietin pre‐conditioning: implications for ischemic and degenerative CNS disorders

Journal of neurochemistry, 2005-04, Vol.93 (2), p.392-402

2005

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(273)
Mit Volltextzugriff
(249)

Publikationsform

Sprache

Englisch
(282)
Japanisch
(42)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The 12th international conference on differentiation therapy: targeting the aberrant growth, differentiation and cell death programs of cancer cells

28-kDa Mammalian Heat Shock Protein, a Novel Substrate of a Growth Regulatory Protease Involved in Differentiation of Human Leukemia Cells (∗)

9-cis Retinoic Acid Induces Complete Remission But Does Not Reverse Clinically Acquired Retinoid Resistance in Acute Promyelocytic Leukemia

9-cis Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein

Acute respiratory distress syndrome, acute kidney injury, and mortality after trauma are associated with increased circulation of syndecan-1, soluble thrombomodulin, and receptor for advanced glycation end products

Adverse events associated with immune checkpoint inhibitor treatment for cancer

Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy

All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-α and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia

Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling

Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal Antibodies

Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study

Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells

Arsenic trioxide decreases AKT protein in a caspase-dependent manner

Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRα phosphorylation

Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation

Arsenic trioxide: Mechanisms of action

Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer

Aspartate 351 of Estrogen Receptor Î± Is Not Crucial for the Antagonist Activity of Antiestrogens

Aspartate 351 of Estrogen Receptor α Is Not Crucial for the Antagonist Activity of Antiestrogens

Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Astroglial cytoprotection by erythropoietin pre‐conditioning: implications for ischemic and degenerative CNS disorders

Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Suchergebnisse filtern